Teva Pharmaceuticals to donate 6 million hydroxychloroquine tablets through wholesalers to hospitals by March 31, and 10 million within a month

Israel’s Teva donating potential COVID-19 treatment to US hospitals

By ISRAEL21c —— Bio and Archives--March 25, 2020

Health and Medicine | Comments | Back To Full Article

The global Israeli company Teva Pharmaceutical Industries is donating more than 6 million doses of hydroxychloroquine sulfate tablets to hospitals across the United States to meet the urgent demand for the medicine as an investigational target to treat COVID-19. Hydroxychloroquine sulfate is approved by the US Food and Drug Administration (FDA) for the treatment of malaria, lupus erythematosus and rheumatoid arthritis.

Read Full Article...

Welcome to CFP’s Comment Section!

The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.

Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.

Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.

We ask only that commenters keep it civil, keep it clean.

Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.

READ OUR Commenting Policy

CFP Comments

Commenting is not available in this channel entry.

Comments

Support Canada Free Press

Recommended by Canada Free Press